Organon & Co.vsThermo Fisher Scientific

OGN and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$692.74

Value $257B

+0.87%
TMO's page

Organon & Co. (OGN) has a market value of $3.6B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, OGN moved +83.7% and TMO +22.6%. The P/E is 17.0 for OGN and 36.4 for TMO. Dividend yield: OGN 0.57%, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    OGN$3.6B

    TMO$257B

    TMO is 71 times OGN

  • Revenue, 12 months

    OGN$6.1B

    TMO$47.4B

    TMO is 7.8 times OGN

  • Net income, 12 months

    OGN$213M

    TMO$7.1B

    TMO is 33 times OGN

  • Operating margin

    OGN–

    TMO17.9%

  • ROIC

    OGN4.2%

    TMO8.2%

    4.0 points apart

  • P/E

    OGN17.0

    TMO36.4

    TMO is 2.1 times OGN

  • Dividend yield

    OGN0.6%

    TMO0.3%

    0.3 points apart

  • 5-year return

    OGN-48.5%

    TMO+10.3%

    58.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

OGN-48.5%

TMO+10.3%

5010020222023202420252026
Returns by period
PeriodOGNWith dividendsTMOWith dividends
1 year since November 17, 2025+83.7%Price +82.0%+22.6%Price +22.1%
3 years since November 17, 2023+35.0%+10.5% a yearPrice +23.1%+50.0%+14.5% a yearPrice +48.5%
5 years since November 17, 2021-48.5%-12.4% a yearPrice -57.8%+10.3%+2.0% a yearPrice +8.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

OGNOrganon & Co.TMOThermo Fisher Scientific

Valuation

OGNTMO
Valuation
Price$13.92$692.74
Market value$3.6B$257B
Enterprise value (EV)$10.7B$293B
P/E17.036.4
P/E, 5-year median5.732.7
P/B3.04.7
EV/EBIT21.334.6
Free cash flow yield18.6%2.9%

Results and growth

OGNTMO
Results and growth
Revenue, 12 months$6.1B$47.4B
Net income, 12 months$213M$7.1B
Free cash flow, 12 months$675M$7.6B
Earnings per share, 12 months$0.77$18.96
Revenue growth, year on year-2.9%3.9%
Revenue growth a year, past-1.0%over 5 years+6.7%over 5 years
EPS growth a year, past-39.0%over 5 years+2.1%over 5 years

Margins and returns on capital

OGNTMO
Margins and returns on capital
Gross margin53.1%–
Operating margin–17.9%
Net margin3.5%14.9%
ROIC4.2%8.2%
ROE22.4%13.4%

Balance sheet

OGNTMO
Balance sheet
Cash$1.5B$6.1B
Total debt$8.6B$41.4B
Net debt / EBITDA10.83.7
Interest cover1.1×5.5×

Dividends and buybacks

OGNTMO
Dividends and buybacks
Dividend yield0.6%0.3%
Dividend per share, 12 months$0.08$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield0.6%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: OGN or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Organon & Co. or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 71.0 times Organon & Co. ($3.6B), at today's prices.

How did OGN and TMO stock do over the last 5 years?

Since November 17, 2021, OGN's price moved -57.8% and TMO's +8.7%. With dividends: OGN -48.5% (-12.4% a year), TMO +10.3% (+2.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, OGN or TMO?

The dividend yield at today's price is 0.57% for Organon & Co. and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid $0.08 and $1.84 per share.

What is the P/E of OGN and TMO?

At today's price, the P/E is 17.0 for OGN and 36.4 for TMO. The median of the last five years was 5.7 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Organon & Co. or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 3.5% for Organon & Co. and 14.9% for Thermo Fisher Scientific, and the operating margin – and 17.9%. Revenue was $6.1B and $47.4B.

Which is the better investment, Organon & Co. or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.